Rankings
▼
Calendar
INDV Q1 2025 Earnings — Indivior Pharmaceuticals Inc Revenue & Financial Results | Market Cap Arena
INDV
Indivior Pharmaceuticals Inc
$4B
Q1 2025 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$266M
-6.3% YoY
Gross Profit
$222M
83.5% margin
Operating Income
$66M
24.8% margin
Net Income
$47M
17.7% margin
EPS (Diluted)
$0.38
QoQ Revenue Growth
-11.0%
Cash Flow
Operating Cash Flow
$75M
Free Cash Flow
$70M
Stock-Based Comp.
$6M
Balance Sheet
Total Assets
$1.4B
Total Liabilities
$1.7B
Stockholders' Equity
-$286M
Cash & Equivalents
$372M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$266M
$284M
-6.3%
Gross Profit
$222M
$246M
-9.8%
Operating Income
$66M
$75M
-12.0%
Net Income
$47M
$61M
-23.0%
Revenue Segments
Reportable Segment
$266M
100%
← FY 2025
All Quarters
Q2 2025 →